...
机译:微管稳定剂帕普匹隆在荷瘤啮齿动物中的药代动力学概况以及与其他MTS的体内外抗癌活性比较
Oncology Research Novartis Institutes for BioMedical Research Novartis Pharma AG Basel 4002 Switzerland;
Oncology Research Novartis Institutes for BioMedical Research Novartis Pharma AG Basel 4002 Switzerland;
Oncology Research Novartis Institutes for BioMedical Research Novartis Pharma AG Basel 4002 Switzerland;
Global Imaging Group Oncology Research Novartis Institutes for BioMedical Research Novartis Pharma AG Basel 4002 Switzerland;
Oncology Research Novartis Institutes for BioMedical Research Novartis Pharma AG Basel 4002 Switzerland;
Oncology Research Novartis Institutes for BioMedical Research Novartis Pharma AG Basel 4002 Switzerland;
Oncology Research Novartis Institutes for BioMedical Research Novartis Pharma AG Basel 4002 Switzerland;
Patupilone; Pharmacokinetics; Colon cancer; P-glycoprotein; Tumor vasculature;
机译:323 POSTER Patupilone是新型微管稳定剂(MTS),在体外和体内均能抵抗过度表达P-gp的人结肠肿瘤细胞的活性;与其他MTS的比较
机译:PET成像比较各种实验肿瘤模型中的[18 sup> F]示踪剂,并鉴定新型微管稳定剂Patupilone的早期反应生物标志物
机译:PET成像比较各种实验肿瘤模型中的[18 sup> F]示踪剂,并鉴定新型微管稳定剂Patupilone的早期反应生物标志物
机译:单聚乙二醇化人甲状旁腺激素的体内/体外生物活性和药代动力学特性研究(1-34)
机译:预测药代动力学特征的体外技术
机译:微管稳定剂帕普匹隆可抵消电离辐射诱导的基质金属蛋白酶活性和肿瘤细胞的侵袭
机译:微管稳定剂帕普匹隆可抵消电离辐射诱导的基质金属蛋白酶活性和肿瘤细胞的侵袭